Despite the epidemiological evidence, there are no published trials regarding the effects of vitamin D supplementation on blood levels of 25 (OH)D, TNF-α, TGF-β1, and TAC in accordance with the different variation of VDR polymorphism among breast cancer women. Here, TGFB1 is linked to breast cancer.